Harrington Discovery Institute is accepting Letters of Intent for the 2026 Harrington Scholar-Innovator Award for physician-scientists. The award offers multiple opportunities for funding in addition to expertise from pharma-experienced leaders with a track record of bringing drugs to market. Intellectual property rights are retained by the award recipient and/or their institution. Up to 12 Scholar-Innovators will be selected to receive:
- $100,000 guaranteed grant award;
- Drug and business development support from Harrington’s Therapeutics Development Center advisors;
- Opportunity to compete for acceleration funds up to $300,000;
- Opportunity to qualify for investment funds typically up to $2M.
Deadline to submit Letter of Intent: June 4, 2025. LEARN MORE>>
This is a great opportunity for physician scientists to collaborate with scientists in programs such as Pharmaceutical Sciences, the Center for Cancer Research, or Physiology on drug development. UTRF is happy to help make connections for this for interested physicians. Connect with UTRF to help make your proposal more competitive! Email James Parrett, JD, PharmD, for assistance.